Synthesis, Characterization and Cytotoxic Evaluation of New Pyrrolo[1,2-b]pyridazines Obtained via Mesoionic Oxazolo-Pyridazinones

New pyrrolo[1,2-b]pyridazines were synthesized by 3 + 2 cycloaddition reaction between mesoionic oxazolo-pyridazinones and methyl/ethyl propiolate. The mesoionic compounds were generated in situ by action of acetic anhydride on 3(2H)pyridazinone acids obtained from corresponding esters by alkaline hydrolysis followed by acidification. The structures of the compounds were confirmed by elemental analyses and IR, 1H-NMR, 13C-NMR, and X-ray diffraction data. The regioselectivity of cycloaddition was evidenced by NMR spectroscopy and confirmed by X-ray analysis. The compounds were evaluated for their cytotoxicity on plant cells (Triticum aestivum L.) and crustacean animal cells (Artemia franciscana Kellogg and Daphnia magna Straus). The results indicated that the tested compounds exhibited low toxicity on the plant cell (IC50 values higher than 200 µM), while on Artemia nauplii no lethality was observed. Daphnia magna assay showed that pyrrolo[1,2-b]pyridazines 5a and 5c could exhibit toxic effects, whereas, for the other compounds, toxicity was low to moderate. Also, the cytotoxic effects of the compounds were tested on three human adenocarcinoma-derived adherent cell lines (colon LoVo, ovary SK-OV-3, breast MCF-7). The in vitro compound-mediated cytotoxicity assays, performed by the MTS technique, demonstrated dose- and time-dependent cytotoxic activity for several compounds, the highest anti-tumor activity being observed for 5a, 2c, and 5f, especially against colon cancer cells.

[1]  Ş. Direkel,et al.  Synthesis, Spectroscopic Characterization, Antibacterial Activity, and Computational Studies of Novel Pyridazinone Derivatives , 2023, Molecules.

[2]  Pragati Silakari,et al.  Pyridazinones: A versatile scaffold in the development of potential target based novel anticancer agents , 2022, Journal of Heterocyclic Chemistry.

[3]  G. Nițulescu,et al.  New Pyrrole Derivatives as Promising Biological Agents: Design, Synthesis, Characterization, In Silico, and Cytotoxicity Evaluation , 2022, International journal of molecular sciences.

[4]  Ibrahim A. Naguib,et al.  Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors , 2022, Molecules.

[5]  S. Saha,et al.  The enthralling effect of Packing on the light emission of pyridazinone based luminophore: Crystallographic, electronic absorption and computational studies. , 2022, Journal of Molecular Structure.

[6]  A. Khlebnikov,et al.  Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity , 2022, Molecules.

[7]  K. Shyamsunder,et al.  Therapeutic potential of pyrrole and pyrrolidine analogs: an update , 2022, Molecular Diversity.

[8]  S Kumar,et al.  Alternative Animal Models in Predictive Toxicology. , 2021, Toxicology.

[9]  G. Nițulescu,et al.  Synthesis and Toxicity Evaluation of New Pyrroles Obtained by the Reaction of Activated Alkynes with 1-Methyl-3-(cyanomethyl)benzimidazolium Bromide , 2021, Molecules.

[10]  V. Nenajdenko,et al.  Copper‐Mediated Oxidative [3+2]‐Annulation of Nitroalkenes and Ylides of 1,2‐Diazines: Assembly of Functionalized Pyrrolo[1,2‐b]pyridazines , 2021, ChemistrySelect.

[11]  Hossein Mousavi A concise and focused overview upon arylglyoxal monohydrates-based one-pot multi-component synthesis of fascinating potentially biologically active pyridazines , 2021, Journal of Molecular Structure.

[12]  M. Bostan,et al.  Anticancer Activity of Some Ruthenium(III) Complexes with Quinolone Antibiotics: In Vitro Cytotoxicity, Cell Cycle Modulation, and Apoptosis-Inducing Properties in LoVo Colon Cancer Cell Line , 2021, Applied Sciences.

[13]  Yi Chen,et al.  Identification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors. , 2020, Bioorganic & medicinal chemistry letters.

[14]  G. Nițulescu,et al.  Rare-Earth Metal Complexes of the Antibacterial Drug Oxolinic Acid: Synthesis, Characterization, DNA/Protein Binding and Cytotoxicity Studies , 2020, Molecules.

[15]  Wen-en Zhao,et al.  Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules. , 2020, European journal of medicinal chemistry.

[16]  G. Nițulescu,et al.  New heteroleptic lanthanide complexes as multimodal drugs: Cytotoxicity studies, apoptosis, cell cycle analysis, DNA interactions, and protein binding , 2020 .

[17]  V. Spanò,et al.  Bioactive pyrrole-based compounds with target selectivity , 2020, European Journal of Medicinal Chemistry.

[18]  Kohske Takahashi,et al.  Create Elegant Data Visualisations Using the Grammar of Graphics [R package ggplot2 version 3.3.2] , 2020 .

[19]  George Mihai Nitulescu,et al.  Artificial Intelligence Algorithms for Discovering New Active Compounds Targeting TRPA1 Pain Receptors , 2020, AI.

[20]  H. Reissig,et al.  The Huisgen Reaction: Milestones of the 1,3‐Dipolar Cycloaddition , 2020, Angewandte Chemie.

[21]  P. Rijo,et al.  Artemia species: An important tool to screen general toxicity samples. , 2020, Current pharmaceutical design.

[22]  David J. Sherman,et al.  Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease , 2020, Molecules.

[23]  I. Mangalagiu,et al.  Microwave Assisted Reactions of Fluorescent Pyrrolodiazine Building Blocks , 2019, Molecules.

[24]  Suat Sarı,et al.  A new series of pyndazinone derivatives as chohnesterases inhibitors: Synthesis, in vitro activity and molecular modeling studies , 2019, Pharmacological reports : PR.

[25]  A. Botezatu,et al.  Modulation of the interplay between p53, ICAM-1 and VEGF in drug-treated LoVo colon cancer cells , 2019, Romanian Biotechnological Letters.

[26]  A. T. Plieva Methods for the synthesis of pyrrolo[1,2-b]pyridazine and pyrrolo[1,2-b]cinnoline derivatives (microreview) , 2019, Chemistry of Heterocyclic Compounds.

[27]  Michael A. Galella,et al.  Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis. , 2019, ACS medicinal chemistry letters.

[28]  R. Danac,et al.  Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives , 2019, Journal of enzyme inhibition and medicinal chemistry.

[29]  D. Lüdecke Sjplot - Data Visualization For Statistics In Social Science. , 2018 .

[30]  M. Badea,et al.  Cytotoxicity studies, DNA interaction and protein binding of new Al (III), Ga (III) and In (III) complexes with 5-hydroxyflavone , 2018, Applied Organometallic Chemistry.

[31]  Saleh A. Ahmed,et al.  Photochromism of Dihydroindolizines. Part XXI: Multiaddressable Photochromic Performances based on Pyrrolo[1,2-b]pyridazine photochromes: Kinetics, Substituent Effect and Solvatochromism , 2017 .

[32]  K. McIntyre,et al.  Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors. , 2017, Bioorganic & medicinal chemistry letters.

[33]  Manuel Koller,et al.  robustlmm : An R Package for Robust Estimation of Linear Mixed-Effects Models , 2016 .

[34]  Florent Baty,et al.  Dose-Response Analysis Using R , 2015, PloS one.

[35]  C. Draghici,et al.  Coumarin substituted pyrrolo-fused heterocyclic systems by 1,3-dipolar cycloadditon reactions , 2015, Monatshefte für Chemie - Chemical Monthly.

[36]  S. Dubey,et al.  Pyridazinone: an important element of pharmacophore possessing broad spectrum of activity , 2015, Medicinal Chemistry Research.

[37]  G. Gribble,et al.  Total synthesis of atorvastatin via a late-stage, regioselective 1,3-dipolar münchnone cycloaddition , 2015 .

[38]  G. Sheldrick SHELXT – Integrated space-group and crystal-structure determination , 2015, Acta crystallographica. Section A, Foundations and advances.

[39]  G. Sheldrick Crystal structure refinement with SHELXL , 2015, Acta crystallographica. Section C, Structural chemistry.

[40]  David S. Nirschl,et al.  Discovery of pyrrolo[1,2-b]pyridazine-3-carboxamides as Janus kinase (JAK) inhibitors. , 2014, Bioorganic & medicinal chemistry letters.

[41]  H. Reissig,et al.  Münchnones--new facets after 50 years. , 2014, Angewandte Chemie.

[42]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[43]  A. Gomtsyan,et al.  Heterocycles in drugs and drug discovery , 2012, Chemistry of Heterocyclic Compounds.

[44]  H. Kohno,et al.  Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF₁) receptor antagonists. , 2012, Bioorganic & medicinal chemistry.

[45]  William N. Venables,et al.  Modern Applied Statistics with S , 2010 .

[46]  Sanford Weisberg,et al.  An R Companion to Applied Regression , 2010 .

[47]  C. Draghici,et al.  New Pyrrolo[1,2‐b]pyridazine Derivatives. , 2010 .

[48]  Masahiro Tanaka,et al.  Discovery of pyrrolopyridazines as novel DGAT1 inhibitors. , 2010, Bioorganic & medicinal chemistry letters.

[49]  Richard J. Gildea,et al.  OLEX2: a complete structure solution, refinement and analysis program , 2009 .

[50]  I. Mangalagiu,et al.  New pyridazine derivatives: synthesis, chemistry and biological activity. , 2009, Bioorganic & medicinal chemistry.

[51]  F. Dumitrascu,et al.  Pyrrolo[1,2-b]pyridazines. A revisit , 2008 .

[52]  M. Caira,et al.  A Novel Approach for the Synthesis of Highly Fluorescent Pyrrolo[1,2-b]pyridazines , 2008 .

[53]  T. Rantala,et al.  Optical spectroscopic characteristics and TD-DFT calculations of new pyrrolo[1,2-b]pyridazine derivatives , 2008 .

[54]  Edsel A. Peña,et al.  Global Validation of Linear Model Assumptions , 2006, Journal of the American Statistical Association.

[55]  M. Poss,et al.  Pyrrolopyridazine MEK inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[56]  S. Sánchez-Fortún,et al.  Effects of selected biocides used in the disinfection of cooling towers on toxicity and bioaccumulation in Artemia larvae , 2005, Environmental toxicology and chemistry.

[57]  R. Huisgen,et al.  A New Type of Mesoionic Aromatic Compound and Its 1,3‐Dipolar Cycloaddition Reactions with Acetylene Derivatives , 1964 .

[58]  J. King,et al.  The Preparation of Some Pyridazonyl Acids , 1952 .

[59]  J. R.,et al.  Chemistry , 1929, Nature.

[60]  Ranjeet Kumar,et al.  Development of robust folded scaffold as fluorescent materials using butylidine linked pyridazinone based systems via aromatic π∙∙∙π Stacking Interactions , 2022, New Journal of Chemistry.

[61]  W. Ollis,et al.  Meso-ionic compounds , 2022, Advances in Heterocyclic Chemistry.

[62]  M. Caira,et al.  Pyrroloquinolines, imidazoquinolines, and pyrroloquinazolines with a bridgehead nitrogen , 2019, Advances in Heterocyclic Chemistry.

[63]  Tony Y. Zhang The Evolving Landscape of Heterocycles in Drugs and Drug Candidates , 2017 .

[64]  O. Olaru,et al.  CHEMICAL , ANTIOXIDANT AND TOXICITY EVALUATION OF ROSEMARY LEAVES AND ITS DRY EXTRACT , 2017 .

[65]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[66]  M. Ferdeș,et al.  REAL-TIME ANALYSIS OF QUERCETIN, RESVERATROL AND /OR DOXORUBICIN EFFECTS IN MCF-7 CELLS , 2013 .

[67]  O. Olaru,et al.  PRELIMINARY RESEARCH ON PORTULACA GRANDIFLORA HOOK. SPECIES (PORTULACACEAE) FOR THERAPEUTIC USE , 2013 .

[68]  A. Botezatu,et al.  GENISTEIN POTENTIATES THE APOPTOTIC EFFECT OF 5-FLUOROURACYL IN COLON CANCER CELL LINES , 2013 .

[69]  Yong-Jin Wu Chapter 1 - Heterocycles and Medicine: A Survey of the Heterocyclic Drugs Approved by the U.S. FDA from 2000 to Present , 2012 .

[70]  C. Davila,et al.  CONTRIBUTIONS TO THE STUDY OF SOME SPECIES IN THE PORTULACA (PORTULACACEAE) GENUS. PRELIMINARY BOTANICAL AND PHYTOBIOLOGICAL RESEARCH ON PORTULACA OLERACEAE L AND PORTULACA GRADIFLORA HOOKER SPECIES , 2011 .

[71]  Brian D. Ripley,et al.  Modern applied statistics with S, 4th Edition , 2002, Statistics and computing.

[72]  C. A. Ramsden,et al.  Meso-ionic heterocycles (1976–1980) , 1982 .

[73]  D. E. Kuhla,et al.  Pyrrolodiazines with a Bridgehead Nitrogen , 1977 .

[74]  J. King,et al.  Hydrazides of Some Pyridazonyl Substituted Acids , 1956 .